Pursuing growth strategies -- diversification, innovation, new products or partnerships -- can indeed stimulate growth. But a study of the Chinese pharmaceutical industry found that these initiatives, when used excessively or in combination, actually depressed growth, notes Freek Vermeulen, a strategy professor at the London Business School. Tackling it all taxes management capacity and "might just be too much of a good thing," he says.

Full Story:
Random Rantings

Related Summaries